Effects of Arylsulfatase B and Pembrolizumab in combination on progression of metastatic melanoma in the B16F10 syngeneic mouse model

• by Sumit Bhattacharyya, Insug O-Sullivan, Joanne K. Tobacman

• June 1, 2026

Rethinking Uveal Melanoma Surveillance

Retrospective study questions whether uveal melanoma liver surveillance period should always be extended after five years

• May 20, 2026

• 3 min

Dana-Farber Researchers Receive AACR 2026 Scientific Achievement Awards

Dr. Eliezer Van Allen and Dr. Kimberly Stegmaier have been selected by the American Association for Cancer Research (AACR) as recipients of 2026 Scientific Achievement Awards. Both researchers will be honored during the AACR Annual Meeting 2026, held April 17-22 at the San Diego Convention Center.

• by

• April 10, 2026

• 4 min

Modeling the Genetics of Uveal Melanoma

Researchers have developed a genetically engineered mouse model that mirrors the genetic evolution of uveal melanoma

• April 21, 2026

• 3 min